Published in Am J Pathol on April 01, 1968
N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A (1975) 9.24
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev (2009) 3.65
Defective granulocyte chemotaxis in the Chediak-Higashi syndrome. J Clin Invest (1971) 3.58
Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A (1981) 3.03
Chemotoxis of mononuclear cells. J Exp Med (1968) 2.95
Pathogenesis of salmonellosis. Studies of fluid secretion, mucosal invasion, and morphologic reaction in the rabbit ileum. J Clin Invest (1973) 2.78
Effects of pneumolysin on human polymorphonuclear leukocytes and platelets. Infect Immun (1981) 2.39
In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils. J Exp Med (1971) 2.36
Acute inflammation. A review. Am J Pathol (1977) 2.06
Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization. J Clin Invest (1980) 2.04
Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med (1982) 2.04
Effect of antibiotics of chemotaxis of human leukocytes. Antimicrob Agents Chemother (1977) 2.04
Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut (1992) 1.94
Chemotactic factor inactivator in normal human serum. J Clin Invest (1973) 1.93
Leukotactic factors elaborated by virus-infected tissues. J Exp Med (1972) 1.89
Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest (1985) 1.79
Leukotactic factors in health and disease. Am J Pathol (1971) 1.71
Chemotaxis of human eosinophils. Am J Pathol (1969) 1.54
Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. J Clin Invest (1979) 1.54
Evaluation of leukocyte chemotaxis in vitro in thermally injured patients. J Clin Invest (1974) 1.45
New aspects of chemotaxis. Specific target-cell attraction by lipid and lipoprotein fractions of Escherichia coli chemotactic factor. Am J Pathol (1975) 1.45
Role of anaerobic coryneforms in specific and non-specific immunological reactions. II. Production of a chemotactic factor specific for macrophages. Immunology (1973) 1.42
Chemotropism indices for polymorphonuclear leukocytes. Biophys J (1976) 1.40
Chemotactic deactivation of human neutrophils: evidence for nonspecific and specific components. Infect Immun (1978) 1.33
Leukotaxis and leukotactic disorders. A review. Am J Pathol (1974) 1.31
Immunocompetent cells in resistance to bacterial infections. Bacteriol Rev (1976) 1.31
Role for endotoxin in the leukocyte infiltration accompanying Escherichia coli inflammation. Infect Immun (1982) 1.29
Hyperactivity of neutrophil leukotactic responses during active bacterial infection. J Clin Invest (1974) 1.29
A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus. J Clin Invest (1978) 1.28
Chemotactic deactivation of human neutrophils: possible relationship to stimulation of oxidative metabolism. Infect Immun (1979) 1.27
A unique complement derived chemotactic factor for tumor cells. Proc Natl Acad Sci U S A (1975) 1.23
Characterization of a class of nonformylated Enterococcus faecalis-derived neutrophil chemotactic peptides: the sex pheromones. Proc Natl Acad Sci U S A (1990) 1.22
The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia. Infect Immun (2004) 1.21
Interactions between human granulocytes and Blastomyces dermatitidis. Infect Immun (1979) 1.21
Aminoglycoside antibiotics moderately impair granulocyte function. Antimicrob Agents Chemother (1978) 1.20
Antileukotactic properties of tumor cells. J Clin Invest (1975) 1.19
Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract. Infect Immun (1985) 1.14
Effect of chemoattractants on chemiluminescence. Infect Immun (1978) 1.14
Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement. Am J Pathol (1978) 1.12
Isolation and partial characterization of a staphylococcal leukocyte cytotaxin. J Bacteriol (1969) 1.12
Multicell simulations of development and disease using the CompuCell3D simulation environment. Methods Mol Biol (2009) 1.08
Chemotaxigenic activity of extracts from the mycelial and spherule phases of Coccidioides immitis for human polymorphonuclear leukocytes. Infect Immun (1978) 1.07
Characterization of the human neutrophil response to sex pheromones from Streptococcus faecalis. Am J Pathol (1989) 1.05
Role of G protein-coupled receptors in inflammation. Acta Pharmacol Sin (2012) 1.05
Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis. Infect Immun (1984) 1.02
Effect of bacterial products on neutrophil migration in vitro. Thorax (1990) 1.01
Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds. Infect Immun (1986) 1.01
Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the management of thermal injuries. Ann Surg (1975) 0.98
Plasma-dependent chemotaxis of macrophages towards mycobacterium tuberculosis and other organisms. Immunology (1972) 0.96
It's a cell-eat-cell world: autophagy and phagocytosis. Am J Pathol (2013) 0.95
Inhibition of leukocyte migration by a staphylococcal factor. J Bacteriol (1969) 0.94
CD8 T cell detection of bacterial infection: sniffing for formyl peptides derived from Mycobacterium tuberculosis. J Exp Med (2001) 0.93
Haematological effects of inhalation of N-formyl-methionyl-leucyl-phenylalanine in man. Thorax (1992) 0.93
Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum. J Clin Invest (1976) 0.92
Comparison of the chemotactic responsiveness of two fibrosarcoma subpopulations of differing malignancy. Am J Pathol (1981) 0.90
Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition. Infect Immun (1982) 0.90
Rous-Whipple award lecture. The formylpeptide receptor of the neutrophil. A search and conserve operation. Am J Pathol (1987) 0.90
A study of the effect of povidone-iodine on polymorphonuclear leucocyte chemotaxis. Br J Exp Pathol (1979) 0.90
Effect of vinblastine on the chemotactic responsiveness of normal human neutrophils. Infect Immun (1973) 0.87
Chemoattractive factors from Escherichia coli: individual strain variation. Infect Immun (1981) 0.86
Inflammatory mediators in culture filtrates of Escherichia coli. Am J Pathol (1975) 0.84
Chemotactic peptides. Mechanisms, functions, and possible role in inflammatory bowel disease. Dig Dis Sci (1988) 0.84
N-formyl-methionyl-leucyl-phenylalanine (fMLP) inhibits tumour necrosis factor-alpha (TNF-alpha) production on lipopolysaccharide (LPS)-stimulated human neutrophils. Clin Exp Immunol (1998) 0.83
Deficiency of the chemotactic factor inactivator in human sera with 1 -antitrypsin deficiency. J Clin Invest (1973) 0.81
Effect of inhaled formyl-methionyl-leucyl-phenylalanine on airway function. Thorax (1988) 0.81
Partial purification and characterization of a formylmethionine deformylase from rat small intestine. Biochem J (1989) 0.80
Impairment of phagocytosis by heterophils from chickens during ochratoxicosis. Appl Environ Microbiol (1980) 0.80
Chemokine research moves on. Exp Cell Res (2011) 0.79
Suppression of polymorphonuclear leucocyte chemotaxis by Pseudomonas aeruginosa elastase in vitro: a study of the mechanisms and the correlation with ring abscess in pseudomonal keratitis. Int J Exp Pathol (1994) 0.78
Lymphocyte-derived chemotactic factor synthesis in initial genital herpesvirus infection: correlation with lymphocyte transformation. Infect Immun (1980) 0.78
Comparative stimulation of granulocyte adherence and chemotaxis by bacterial products. Infect Immun (1980) 0.77
Motility of rabbit alveolar cells: role of unsaturated fatty acids. Am J Pathol (1979) 0.77
Suppression of acute and chronic inflammation in tumor-bearing rats. J Clin Invest (1979) 0.76
On being a pathologist. Hum Pathol (2008) 0.75
Inhibitory effect of heparin on leucocyte chemotactic factors. Clin Exp Immunol (1980) 0.75
Interference of granulocyte function by the vehicle of miconazole. Antimicrob Agents Chemother (1978) 0.75
Neutrophil chemotaxis in patients with Staphylococcus aureus furunculosis. Infect Immun (1979) 0.75
In vitro and in vivo production of chemotactic inhibitors by tumor cells. Am J Pathol (1979) 0.75
The gel-filtration behaviour of proteins related to their molecular weights over a wide range. Biochem J (1965) 30.51
The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med (1962) 23.03
Role of chemotaxis in inflammation. Physiol Rev (1954) 8.58
THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO. J Exp Med (1965) 8.31
Further studies on the chemotactic factor of complement and its formation in vivo. Immunology (1966) 7.59
A plasmin-split fragment of C'3 as a new chemotactic factor. J Exp Med (1967) 4.94
Mechanisms of the inhibition of chemotaxis by phosphonate esters. J Exp Med (1967) 3.87
Partial biochemical characterization of the activated esterase required in the complement-dependent chemotaxis of rabbit polymorphonuclear leukocytes. J Exp Med (1967) 3.15
SUBSTANCES PROMOTING LEUKOCYTE EMIGRATION. Ann N Y Acad Sci (1964) 2.62
Mobilization of defensive cells in inflammatory tissue. Bacteriol Rev (1960) 1.85
Further studies on the chemotactic factor of complement and its formation in vivo. Immunology (1966) 7.59
Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science (1989) 4.99
A plasmin-split fragment of C'3 as a new chemotactic factor. J Exp Med (1967) 4.94
The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase. J Exp Med (1968) 4.79
A neutrophil chemotactic factor from human C'5. J Immunol (1969) 4.46
Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol (1982) 4.38
Properties of highly purified human properdin. J Immunol (1968) 3.96
Leukotactic factor produced by sensitized lymphocytes. Science (1969) 3.95
Mechanisms of the inhibition of chemotaxis by phosphonate esters. J Exp Med (1967) 3.87
Functional relationship of factor B in the properdin system to C3 proactivator of human serum. J Immunol (1971) 3.81
C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J Immunol (1970) 3.75
Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun (1988) 3.63
Adhesion molecules and inflammatory injury. FASEB J (1994) 3.53
Acute immunologic pulmonary alveolitis. J Clin Invest (1974) 3.53
The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J Immunol (1975) 3.50
Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. J Clin Invest (1982) 3.49
Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci U S A (1999) 3.49
Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J Biol Chem (1984) 3.32
Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet (1994) 3.22
The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. Cell Immunol (1970) 3.17
Partial biochemical characterization of the activated esterase required in the complement-dependent chemotaxis of rabbit polymorphonuclear leukocytes. J Exp Med (1967) 3.15
Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement. J Exp Med (1967) 3.05
The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med (1971) 2.95
Chemotoxis of mononuclear cells. J Exp Med (1968) 2.95
Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science (1993) 2.71
The chemosuppression of chemotaxis. J Exp Med (1966) 2.62
Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury. J Clin Invest (1983) 2.52
Protective effects of C5a blockade in sepsis. Nat Med (1999) 2.50
Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest (1991) 2.50
Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci U S A (1991) 2.49
Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140). J Clin Invest (1992) 2.47
Role of oxygen metabolites in immune complex injury of lung. J Immunol (1981) 2.39
Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem (1990) 2.37
In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils. J Exp Med (1971) 2.36
Complement-derived leukotactic factors in inflammatory synovial fluids of humans. J Clin Invest (1971) 2.35
Neutrophil aggregation and swelling induced by chemotactic agents. J Immunol (1977) 2.26
Evidence for soluble immune complexes in the pathogenesis of the glomerulonephritis of quartan malaria. Lancet (1969) 2.22
C3 leukotactic factors produced by a tissue protease. J Exp Med (1969) 2.19
Human herpesvirus 6 in salivary glands. Lancet (1990) 2.15
Biochemical demonstration of the activatable esterase of the rabbit netrophil involved in the chemotactic response. J Immunol (1970) 2.12
In vivo damage of rat lungs by oxygen metabolites. J Clin Invest (1981) 2.10
In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J Clin Invest (1997) 2.04
Glomerular and dermal depostion of properdin in systemic lupus erythematosus. N Engl J Med (1972) 2.01
Pulmonary endothelial cell killing by human neutrophils. Possible involvement of hydroxyl radical. Lab Invest (1985) 2.01
Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin. Am J Pathol (1979) 1.96
Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J Immunol (1996) 1.95
C5a-induced expression of P-selectin in endothelial cells. J Clin Invest (1994) 1.93
Chemotactic factor inactivator in normal human serum. J Clin Invest (1973) 1.93
Chemotactic factor influences on the aggregation, swelling, and foreign surface adhesiveness of human leukocytes. Am J Pathol (1978) 1.91
Generation of chemotactic activity in rabbit serum by plasminogen-streptokinase mixtures. J Exp Med (1967) 1.90
Leukotactic factors elaborated by virus-infected tissues. J Exp Med (1972) 1.89
Neutropenia induced by systemic infusion of chemotactic factors. J Immunol (1977) 1.89
Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology (1989) 1.88
Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator. N Engl J Med (1974) 1.88
Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J Clin Invest (1989) 1.86
Anaphylatoxin formation by purified human C'1 esterase. J Immunol (1965) 1.80
The relationship of glycine-rich -glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of huan serum. J Exp Med (1973) 1.80
Acute inflammatory pulmonary reactions induced by chemotactic factors. Am J Pathol (1979) 1.79
Impaired leucotactic responsiveness in a child with recurrent infections. Lancet (1969) 1.78
Selective neutrophil desensitization to chemotactic factors. J Cell Biol (1979) 1.77
Requirement and role of C5a in acute lung inflammatory injury in rats. J Clin Invest (1996) 1.77
Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol (1993) 1.74
Leukotactic factors in health and disease. Am J Pathol (1971) 1.71
Impaired neutrophil chemotaxis in patients with juvenile and rapidly progressing periodontitis. J Periodontal Res (1979) 1.70
Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol (1993) 1.68
Neutrophil chemotactic factors and related clinical disorders. Arthritis Rheum (1970) 1.68
Molecular cloning and characterization of DEFCAP-L and -S, two isoforms of a novel member of the mammalian Ced-4 family of apoptosis proteins. J Biol Chem (2000) 1.66
Lung and dermal vascular injury produced by preformed immune complexes. Am Rev Respir Dis (1978) 1.64
Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis (1984) 1.64
C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation. J Clin Invest (1979) 1.63
Host defense against Neisseria meningitidis requires a complement-dependent bactericidal activity. Science (1979) 1.62
Isolation from human serum of an inactivator of bacterial lipopolysaccharide. Am J Pathol (1977) 1.58
Multiple sedimenting species of properdin in human serum and interaction of purified properdin with the third component of complement. J Exp Med (1976) 1.58
Influence of inhibitors of cellular function on chemotactic factor-induced neutrophil aggregation. J Immunol (1977) 1.57
Studies on the sub-unit structure of human properdin. Immunochemistry (1974) 1.57
Two distinct chemotactic factor inactivators in human serum. J Immunol (1975) 1.55
Inhibition of in vivo and in vitro neutrophil responses to chemotactic factors by a competitive antagonist. J Immunol (1978) 1.55
Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases. Am J Pathol (1989) 1.55
Chemotaxis of human eosinophils. Am J Pathol (1969) 1.54
Gastrointestinal milk intolerance of infancy. Am J Dis Child (1989) 1.54
Role of C5a in multiorgan failure during sepsis. J Immunol (2001) 1.53
Chemotaxis of rat lymphocytes. J Immunol (1977) 1.53
Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J Immunol (1995) 1.53
Role of macrophage inflammatory protein-1 alpha (MIP-1 alpha) in acute lung injury in rats. J Immunol (1995) 1.52
Biologic role of complement products. Complement-derived leukotactic activity extractable from lesions of immunologic vasculitis. J Immunol (1972) 1.51
Leukotactic dystunction in sarcoidosis. Ann Intern Med (1976) 1.50
Suppression by superoxide dismutase of immune-complex--induced pulmonary alveolitis and dermal inflammation. Am J Pathol (1981) 1.50
Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J (1989) 1.49
Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest (1993) 1.49
Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J Clin Invest (2000) 1.49
Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am J Pathol (1997) 1.49
Chemoattractants of leukocytes, with special reference to lymphocytes. Fed Proc (1972) 1.48
Biochemical quantitation of the chemotactic factor inactivator activity in human serum. J Lab Clin Med (1979) 1.46
In vitro and in vivo stimulation of rat neutrophils and alveolar macrophages by immune complexes. Production of O-2 and H2O2. Am J Pathol (1983) 1.46
Congenital 21-hydroxylase deficiency as a new deletion mutation. Detection in a proband during subsequent prenatal diagnosis by HLA typing and DNA analysis. Hum Immunol (1992) 1.45
In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha. J Immunol (1999) 1.45
Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature (1993) 1.43
Mediators of ischemia-reperfusion injury of rat lung. Am J Pathol (1997) 1.43